LNTH Q3 2019 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q3 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$86M-3.5% YoY

Gross Profit

$42M48.5% margin

Operating Income

$9M9.9% margin

Net Income

$5M5.7% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+0.1%

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$23M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$402M

Total Liabilities

$301M

Stockholders' Equity

$101M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$89M	-3.5%
Gross Profit	$42M	$45M	-7.3%
Operating Income	$9M	$16M	-48.3%
Net Income	$5M	$9M	-47.6%

Revenue Segments

US Segment

$149M87%

International Segment

$22M13%